COX-1/-2 and the microsomal form of human prostaglandin E synthase 1 (mPGES1) are both known to be overexpressed in NSCLC cells, suggesting a potential role for COXi in enhancing ICIs’ efficacy also in this scenario [30]. This evidence concerns the gene MT-CO1 and non-small cell lung carcinoma.